Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
Myocardial Infarction Market Growth Forecast 2024-2033: What’s the Expected Rate?
In recent times, the myocardial infarction market has seen a robust expansion. Expected to surge from $1.9 billion in 2023 to $2.04 billion in 2024, it predicts a compound annual growth rate (CAGR) of 7.7%. The notable growth in the preceding years can be credited to the introduction of beta-blockers, the establishment of chest pain centers, the enactment of thrombolytic therapies, genomic and personalized medicine approaches, and the use of wearable cardiovascular devices.
Strong expansion is anticipated within the myocardial infarction market in the upcoming years, with its size predicted to reach $2.68 billion by 2028, experiencing a compound annual growth rate (CAGR) of 7.1%. This projected growth during the forecast period can be linked to several factors including global health programs for cardiovascular health, increased availability of reperfusion therapies, RNA therapeutics developed for cardiovascular diseases, emphasis on patient-centric care models, addressing of microvascular dysfunction, and prominence of bioelectronic medicine. The period is also expected to witness major trends such as improvements in cardiovascular imaging, enhancements in cardiac surgery techniques, progressions in telemedicine, application of artificial intelligence in diagnosis, the creation of digital biomarkers for risk assessment, use of blockchain to secure healthcare data, AI-driven drug discovery, and innovations in technologies for cardiac rehabilitation.
Claim Your Free Sample of the Global Myocardial Infarction Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12164&type=smp
What Factors Are Impacting the Growth of the myocardial infarction Market?
The growth of the myocardial infarction market is forecasted to be driven by a surge in the number of smokers. Smokers are individuals who consume cigarettes, cigars, or a pipe. The chemicals found in cigarette smoke are known to induce blood thickening and clotting in veins and arteries, leading to myocardial infarction as a result of blockage caused by a clot. For example, statistics from the UK’s Office for National Statistics in September 2023 showed that the highest proportion of smokers were aged between 25 and 34 years. They represented 16.3% or around 1.4 million people in 2022, a rise from 15.8% or about 1.3 million people the previous year. As such, the increase in smokers is a major contributor to the expansion of the myocardial infarction market.
What Are the Fundamental Segments in the Myocardial Infarction Market?
1) By Drug Class: Antiplatelet Agents, Glycoprotein IIb/IIIa Inhibitors, Antithrombotic Agents, Beta-adrenergic Blockers, Vasodilators, Angiotensin-converting Enzyme (ACE) Inhibitors, Angiotensin-receptor Blockers, Analgesics, Thrombolytics
2) By Route Of Administration: Oral, Injectable
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
What Trends Are Shaping the New Direction of the Myocardial Infarction Market?
Leading businesses in the myocardial infarction market are directing their efforts towards the creation of new medicines such as anti-inflammatory drugs, with an aim to provide targeted treatment for cardiovascular inflammation, thereby gaining a competitive advantage. These anti-inflammatory medications work by lessening inflammation and addressing pain and swelling through the targeting of the body’s immune response. In June 2023, Agepha Pharma, an established medical product manufacturer based in Slovakia, obtained FDA clearance for its drug, Lodoco (colchicine). Of note is the fact that Lodoco is the pioneer anti-inflammatory medication aimed at the primary cause of atherosclerotic cardiovascular disease. The primary goal of Lodoco is to lower the likelihood of myocardial infarction, stroke, coronary revascularization, and cardiovascular death in adult patients. It can be utilized singularly or in conjunction with cholesterol-reducing medications. Clinical trials illustrated that Lodoco, a reformulated low-dose colchicine, resulted in a 31% decrease in the overall risk of cardiovascular death, myocardial infarction, stroke, or coronary revascularization.
Order Now for Fast Delivery of Your Myocardial Infarction Market Report!
https://www.thebusinessresearchcompany.com/report/myocardial-infarction-global-market-report
Which Regions Are Making a Mark in the Myocardial Infarction Market Growth?
North America was the largest region in the myocardial infarction market in 2023. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the myocardial infarction market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The Myocardial Infarction Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the myocardial infarction market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Myocardial Infarction Market Include
1. Myocardial Infarction Market Executive Summary
2. Myocardial Infarction Market Segments
3. Myocardial Infarction Market Size And Template Market Growth Rate
4. Key Myocardial Infarction Market Trends
5. Major Myocardial Infarction Market Drivers
……
25. Key Mergers And Acquisitions In The Myocardial Infarction Market
26. Top Myocardial Infarction Companies
27. Myocardial Infarction Market Opportunities And Strategies
28. Myocardial Infarction Market, Conclusions And Recommendations
29. Appendix
Discover Related Reports by The Business Research Company:
Medical Device Outsourcing Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/medical-device-outsourcing-global-market-report
Regulatory Affairs Outsourcing Global Market Report 2024
Legal Software (focus on machine learning) Global Market Report 2024
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
